PharmaCompass

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

News

Evonik sets new dividend policy, meets guidance for 2025

05 Feb 2026

// PRESS RELEASE

Evonik marks 50 years at IPPE with focus on amino acids

26 Jan 2026

// PRESS RELEASE

Evonik Unveils Recycled TROGAMID® R with Poliplastic

23 Jan 2026

// PRESS RELEASE

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

RNA Leaders

Attending

Book a meeting

envelop Contact Supplier

CATEGORY PAGE

Evonik

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2024, Corporate Presentation, GMP Certificate 2024, Rexiva®, Lipid-based Delivery of Nucleic Acids, PhytoSquene®, Nutraceutical Solutions, Evonik Strengthens its Animal Nutrition Business, New U.S Facility for Pharmaceutical Lipids, Production Capacity for DL-Methionine in Singapore, Evonik invests $220M with US Govt. for lipid production facility, Specialty Additives Division Spotlight, cQrex™ Cell Culture Solutions, Complex Parenterals, Exclusive Synthesis, Oral Drug Delivery Solutions, Resomer® , Nutrition & Care Divison Spotlight, Smart Materials Division Spotlight, Eudragit®, PhytoChol®, Custom Lipids, Evonik Birmingham Laboratories, High-quality Generic APIs, Intermediates & Amino Acids, Your Enabling Partner for Oral Drug Delivery Solutions

Product List 2024
Corporate Presentation
GMP Certificate 2024
Rexiva®
Lipid-based Delivery of Nucleic Acids
PhytoSquene®
Nutraceutical Solutions
Evonik Strengthens its Animal Nutrition Business
New U.S Facility for Pharmaceutical Lipids
Production Capacity for DL-Methionine in Singapore
Evonik invests $220M with US Govt. for lipid production facility
Specialty Additives Division Spotlight
cQrex™ Cell Culture Solutions
Complex Parenterals
Exclusive Synthesis
Oral Drug Delivery Solutions
Resomer®
Nutrition & Care Divison Spotlight
Smart Materials Division Spotlight
Eudragit®
PhytoChol®
Custom Lipids
Evonik Birmingham Laboratories
High-quality Generic APIs, Intermediates & Amino Acids
Your Enabling Partner for Oral Drug Delivery Solutions

VIDEO(s)

Applied Technology Center, Catalysts - Adsorbent Solutions, Custom Catalysts, Interface & Performance Laboratory, TEGO® Foamex 8880, Lipid Innovation Center, Discover Our New Oral Drug Delivery Lab in Istanbul, CDMO for Advanced Drug Delivery, EUDRATEC® SoluFlow, Drawing Drug Delivery: Liposomes, Evonik Delivers First Lipids from German Facility to BioNTech, Hydrogen Peroxide, Polyamide 12, SEPURAN® Green, Specialty Additives

Applied Technology Center
Catalysts - Adsorbent Solutions
Custom Catalysts
Interface & Performance Laboratory
TEGO® Foamex 8880
Lipid Innovation Center
Discover Our New Oral Drug Delivery Lab in Istanbul
CDMO for Advanced Drug Delivery
EUDRATEC® SoluFlow
Drawing Drug Delivery: Liposomes
Evonik Delivers First Lipids from German Facility to BioNTech
Hydrogen Peroxide
Polyamide 12
SEPURAN® Green
Specialty Additives

DIGITAL CONTENT

40 Corporate Content #SupplierSpotlight, 8 Data Compilation #PharmaFlow, 259 News #PharmaBuzz

40 Corporate Content #SupplierSpotlight
8 Data Compilation #PharmaFlow
259 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

53 All APIs, 14 USDMF, 18 CEP/COS, 25 JDMF, 7 KDMF, 21 NDC API, 2 VMF

53 All APIs
14 USDMF
18 CEP/COS
25 JDMF
7 KDMF
21 NDC API
2 VMF

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

SERVICES

API Manufacturing, Drug Product Manufacturing, API & Drug Product Development

API Manufacturing
Drug Product Manufacturing
API & Drug Product Development
- 3 API Development
- 5 Formulation Development

KEY SERVICES

Oral Technologies, CMO for Controlled Substances, Microbial Fermentation, API Contract Manufacturing, Chiral Synthesis, Drug Delivery Technology, Hot Melt Extrusion, Coating Technology, CDMO for HPAPIs

Oral Technologies
CMO for Controlled Substances
Microbial Fermentation
API Contract Manufacturing
Chiral Synthesis
Drug Delivery Technology
Hot Melt Extrusion
Coating Technology
CDMO for HPAPIs

EXCIPIENTS

29 All Excipients, 28 USDMF, 1 NDC API, 2 VMF, 44 Listed Products

29 All Excipients
28 USDMF
1 NDC API
2 VMF
44 Listed Products

EXCIPIENTS BY INGREDIENTS

Ethyl Acrylate and Methyl Methacrylate Copolymer, Amino Methacrylate Copolymer, Methacrylic Acid Methyl Methacrylate Copolymer, Methacrylic Acid - Ethyl Acrylate Copolymer, Methyl Methacrylate, Methacrylic Acid Excipient, L-Lysine Monohydrate, PLASACRYL HTP20, DL-Glutamic Acid, Methacrylic Acid Methyl Methacrylate Copolymer 1:2 , L Methionine, L Threonine Excipient, L-Aspartic Acid, Ammonio Methacrylate Copolymer Excipient, L-Proline, L-Alanine, Methyl Acrylate, Glycine Excipient, L-Serine, DL-Methionine Excipient, L-Lysine Hydrochloride, N-AC-DL-Methionine, L-Phenylalanine, L-Leucine, L-Ornithine L-Aspartate Excipient, L-Lysine Acetate, Ammonio Methacrylate Copolymer Type B, L-Asparagine Hydrate, Ammonia Methacrylate Copolymer Type A, L-Arginine L-Aspartate Excipient, L-Valine Excipient, L-Lysine L-Aspartate Excipient, PLASACRYL T20

Ethyl Acrylate and Methyl Methacrylate Copolymer
Amino Methacrylate Copolymer
Methacrylic Acid Methyl Methacrylate Copolymer
Methacrylic Acid - Ethyl Acrylate Copolymer
Methyl Methacrylate
Methacrylic Acid Excipient
L-Lysine Monohydrate
PLASACRYL HTP20
DL-Glutamic Acid
Methacrylic Acid Methyl Methacrylate Copolymer 1:2
L Methionine
L Threonine Excipient
L-Aspartic Acid
Ammonio Methacrylate Copolymer Excipient
L-Proline
L-Alanine
Methyl Acrylate
Glycine Excipient
L-Serine
DL-Methionine Excipient
L-Lysine Hydrochloride
N-AC-DL-Methionine
L-Phenylalanine
L-Leucine
L-Ornithine L-Aspartate Excipient
L-Lysine Acetate
Ammonio Methacrylate Copolymer Type B
L-Asparagine Hydrate
Ammonia Methacrylate Copolymer Type A
L-Arginine L-Aspartate Excipient
L-Valine Excipient
L-Lysine L-Aspartate Excipient
PLASACRYL T20

EXCIPIENTS BY APPLICATIONS

Controlled & Modified Release, Solubilizers, Coating Systems & Additives, Topical, Film Formers & Plasticizers, Taste Masking, Thickeners and Stabilizers, Fillers, Diluents & Binders, Lubricants & Glidants, Disintegrants & Superdisintegrants

Controlled & Modified Release
Solubilizers
Coating Systems & Additives
Topical
Film Formers & Plasticizers
Taste Masking
Thickeners and Stabilizers
Fillers, Diluents & Binders
Lubricants & Glidants
Disintegrants & Superdisintegrants

INSPECTIONS & REGISTRATIONS

80 FDA, 28 EDQM, 2 GDUFA, 3 Third-Party Audit

80 FDA
28 EDQM
2 GDUFA
3 Third-Party Audit

PC100329

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Others: Evonik invests US$220M in partnership with the U.S. Government - Evonik

CATEGORY PAGE

Evonik

VIRTUAL BOOTH

CONTACT DETAILS

Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

VIDEO(s)

DIGITAL CONTENT

40 Corporate Content #SupplierSpotlight

8 Data Compilation #PharmaFlow

259 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

DEVELOPMENTS

8 Drugs in Development

SERVICES

API Manufacturing

Drug Product Manufacturing

API & Drug Product Development

KEY SERVICES

EXCIPIENTS

EXCIPIENTS BY INGREDIENTS

EXCIPIENTS BY APPLICATIONS

INSPECTIONS & REGISTRATIONS